◆ Market Terminal AILook up a stock

First Tracks Biotherapeutics Inc (TRAX)

Healthcare · Biotechnology · Small-cap · updated October 16, 2026

NOT A BUY TODAY
What this means. First Tracks Biotherapeutics Inc is an average business by our measures, its shares look fairly priced, and its share price has been weak.
Value45
Quality51
Price trend13
Overall40
2321 of 2764rank among the US stocks we score (our core model buys the top 15)
16%of US stocks we score rank below it

Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.

Insider trades, last 90 days

No open-market buys or sells by its directors or officers in the last 90 days.

Higher-scoring in the same industry

Interactive lookupGet the Ledger every Monday

Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy